Samson, André L. http://orcid.org/0000-0002-0637-2716
Fitzgibbon, Cheree
Patel, Komal M.
Hildebrand, Joanne M. http://orcid.org/0000-0002-1456-2042
Whitehead, Lachlan W. http://orcid.org/0000-0002-4388-9642
Rimes, Joel S.
Jacobsen, Annette V. http://orcid.org/0000-0003-0252-7685
Horne, Christopher R. http://orcid.org/0000-0003-1318-514X
Gavin, Xavier J.
Young, Samuel N.
Rogers, Kelly L. http://orcid.org/0000-0002-6755-0221
Hawkins, Edwin D.
Murphy, James M. http://orcid.org/0000-0003-0195-3949
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1172929, 9000653, 1124735, 1124737)
Article History
Received: 26 October 2020
Revised: 20 January 2021
Accepted: 25 January 2021
First Online: 15 February 2021
Compliance with ethical standards
:
: ALS, CF, KP, JMH, SNY, and JMM contribute to a project developing necroptosis inhibitors in collaboration with Anaxis Pharma. The other authors declare no competing interests.
: All animal procedures were approved by and conducted in accordance with the Animal Ethics Committee of the Walter and Eliza Hall Institute, Australia.
: All materials will be provided under Materials Transfer Agreement upon request to JMM (jamesm@wehi.edu.au).